| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AN2 Therapeutics, Inc. | Principal Accounting Officer | Common Stock | 67,175 | $88,671 | $1.32 | 20 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | 20 Feb 2026 | 1 | $0 | 4 | Principal Accounting Officer | 23 Feb 2026, 16:39 |
| ANTX | AN2 Therapeutics, Inc. | 26 Jan 2026 | 0 | $0 | 3 | Principal Accounting Officer | 03 Feb 2026, 18:08 |